AFG
LFCR icon

Allegheny Financial Group’s Lifecore Biomedical LFCR Stock Holding History

Allegheny Financial Group’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,397
Closed -$51.3K – 244
2024
Q3 		$51.3K Buy
10,397
+312
+3% +$1.63K 0.01% 238
2024
Q2 		$51.7K Buy
+10,085
New +$59.7K 0.01% 216

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Allegheny Financial Group's LFCR Position: Q4 2024 in Review

Allegheny Financial Group sold out of Lifecore Biomedical (LFCR) in Q4 2024, closing a stake of 10,397 shares — an estimated $51.3K sold.

Allegheny Financial Group first reported a position in LFCR in Q2 2024 and held it in 2 quarters. The position peaked at $51.7K in Q2 2024. 77 funds tracked by Wall St. Rank hold LFCR as of Q4 2024.

  • Allegheny Financial Group reported no remaining Lifecore Biomedical position as of Q4 2024 after selling out during the quarter.
  • Allegheny Financial Group sold 10,397 Lifecore Biomedical shares in Q4 2024, an estimated $51.3K.
  • Allegheny Financial Group first reported a position in Lifecore Biomedical in Q2 2024 and held it in 2 quarters.
  • Allegheny Financial Group's Lifecore Biomedical position peaked at $51.7K in Q2 2024.
  • 77 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2024.

Based on Allegheny Financial Group's 13F filing for Q4 2024, filed 14 Feb 2025.